We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-9.68%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$80.4M
AUM Growth
-$41.9M
Cap. Flow
-$30.5M
Cap. Flow %
-37.98%
Top 10 Hldgs %
79.62%
Holding
53
New
1
Increased
2
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.99M
2
ACLX
Arcellx
ACLX
+$1.49M
3
ELEV
Elevation Oncology
ELEV
+$52K

Top Sells

Rank Stock Value
1
CRDF icon
Cardiff Oncology
CRDF
+$15.2M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$5.72M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.55M
4
LUXA
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
+$1.96M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 57.31%
2 Financials 10.5%
3 Communication Services 5.09%
4 Technology 4.29%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHTR icon
26
Charter Communications
CHTR
$17.3B
$660K 0.82%
1,210
-20
-2% -$11.7K
META icon
27
Meta Platforms (Facebook)
META
$1.49T
$621K 0.77%
2,791
-49
-2% -$12.2K
NFLX icon
28
Netflix
NFLX
$307B
$556K 0.69%
14,840
-290
-2% -$12.1K
CDLX icon
29
Cardlytics
CDLX
$22.2M
$470K 0.58%
854
-20
-2% -$12.1K
PYPL icon
30
PayPal
PYPL
$50.3B
$409K 0.51%
3,538
-95
-3% -$12.6K
CVNA icon
31
Carvana
CVNA
$47.5B
$385K 0.48%
16,120
-460
-3% -$13.4K
ELEV
32
DELISTED
Elevation Oncology
ELEV
$172K 0.21%
68,279
+12,980
+23% +$52K
RMGCU
33
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$109K 0.14%
11,000
– –
LUXAW
34
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$28K 0.03%
66,666
– –
BTWNW
35
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$23K 0.03%
39,773
– –
PV.WS
36
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$5K 0.01%
12,000
– –
FLACW
37
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$4K 0.01%
21,333
– –
CRDF icon
38
Cardiff Oncology
CRDF
$63M
– –
-2,522,083
Closed -$15.2M
EFA icon
39
iShares MSCI EAFE ETF
EFA
$76.4B
– –
-19,000
Closed -$1.5M
KALA icon
40
KALA BIO
KALA
$12.5M
– –
-5
Closed -$16K
MLTX icon
41
MoonLake Immunotherapeutics
MLTX
$1.56B
– –
-16,009
Closed -$158K
AAC.U
42
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
– –
-139,680
Closed -$1.39M
BTWN
43
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
– –
-62,688
Closed -$616K
SVFA
44
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
– –
-27,900
Closed -$280K
SCOAU
45
DELISTED
ScION Tech Growth I Unit
SCOAU
– –
-22,410
Closed -$223K
PV
46
DELISTED
Primavera Capital Acquisition Corporation
PV
– –
-24,000
Closed -$233K
SSAAU
47
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
– –
-62,000
Closed -$613K
HMCOU
48
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
– –
-57,724
Closed -$585K
FLAC
49
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
– –
-64,000
Closed -$624K
LUXA
50
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
– –
-200,000
Closed -$1.96M
1
2
3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
KI
Khan Imran $2.93M AUM
1IC
1922 Investment Company Houston, Texas $2.92M AUM 1.93% 1-Year Est. Return

Caxton Corporation's Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Corporation held 53 positions worth $80.4M, down 34% from $122M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Caxton Corporation withdrew a net $30.5M in Q1 2022, closing 16 positions and reducing 24 holdings. Its most notable exit was Cardiff Oncology, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 66% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Caxton Corporation opened a new position in Arcellx worth $1.25M.

  • Caxton Corporation's largest Q1 2022 buy was Arcellx: 88,820 shares worth $1.25M.
  • Caxton Corporation added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $3.99M increase.
  • Caxton Corporation's biggest Q1 2022 reduction was Xeris Biopharma Holdings, cutting an estimated $663K.
  • Caxton Corporation fully exited Cardiff Oncology in Q1 2022, selling an estimated $15.2M.
  • Caxton Corporation's ten largest holdings make up 80% of its $80.4M portfolio in Q1 2022.
  • Caxton Corporation opened 1 new position and closed 16 in Q1 2022.
  • Caxton Corporation's portfolio value fell 34% quarter-over-quarter to $80.4M.

Based on Caxton Corporation's 13F filing for Q1 2022, filed 16 May 2022.